testing an emerging animal model for use in the allergenicity assessment of food

1
MEETING ABSTRACT Open Access Testing an emerging animal model for use in the allergenicity assessment of food David E Lefebvre 1* , Nikia Ross 1 , Laurie Coady 1 , Cheryl Armstrong 1 , Susan Gurofsky 1 , Ivan Curran 1 , Tim Schrader 1 , Don Caldwell 2 , Genevieve S Bondy 1 From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2011 Quebec, Canada. 20-23 October 2011 Background The regulatory assessment of novel food includes tests for allergy. The World Health Organization suggests tests in an animal model of allergy despite the lack of a validated model. We aimed to confirm if C3H/HeJ mice would respond to food of high allergenic potential (peanut), but not to food of low allergenic potential (turkey, potato, spinach). Methods In the first study, C3H/HeJ mice were orally treated, once per week for two weeks, with adjuvant and 0 or 2 mg of peanut or turkey. A second study used adjuvant and 0, 0.1, 1 or 2 mg of peanut, potato or spinach. Blood IgE antibodies and spleen interleukin-4 were quantified. Results Mice treated with 2 mg peanut developed peanut-specific IgE levels which were significantly higher than control mice (p<0.001, n=10/group). Mice treated with 2 mg tur- key developed a similar IgE response to turkey (p<0.001, n=10/group). In the second study, allergy was only trig- gered in one of ten mice treated with 2 mg peanut. Two of ten mice exposed to 1 mg potato had a response. There were no IgE responders to spinach. Spleen cells from both the peanut- and the spinach-treated mice secreted more allergy-promoting interleukin-4 than con- trols (p<0.01, n=7-24/group). Levels were not modified in potato-treated mice. Conclusions C3H/HeJ mice developed food allergy markers to peanut. However, the incidence varied between experiments. Some mice developed a similar response to foods with low allergenic potential. Thus, this model may not be appropriate for safety assessment of novel food. Author details 1 Toxicology Research Division, Bureau of Chemical Safety, Food Directorate, Health Canada, Ottawa, ON, K1A 0L2, Canada. 2 Scientific Services Division, Bureau of Chemical Safety, Food Directorate, Health Canada, Ottawa, ON, K1A 0L2, Canada. Published: 14 November 2011 doi:10.1186/1710-1492-7-S2-A1 Cite this article as: Lefebvre et al.: Testing an emerging animal model for use in the allergenicity assessment of food. Allergy, Asthma & Clinical Immunology 2011 7(Suppl 2):A1. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit 1 Toxicology Research Division, Bureau of Chemical Safety, Food Directorate, Health Canada, Ottawa, ON, K1A 0L2, Canada Full list of author information is available at the end of the article Lefebvre et al. Allergy, Asthma & Clinical Immunology 2011, 7(Suppl 2):A1 http://www.aacijournal.com/content/7/S2/A1 ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY © 2011 Lefebvre et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upload: david-e-lefebvre

Post on 06-Jul-2016

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Testing an emerging animal model for use in the allergenicity assessment of food

MEETING ABSTRACT Open Access

Testing an emerging animal model for use in theallergenicity assessment of foodDavid E Lefebvre1*, Nikia Ross1, Laurie Coady1, Cheryl Armstrong1, Susan Gurofsky1, Ivan Curran1, Tim Schrader1,Don Caldwell2, Genevieve S Bondy1

From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2011Quebec, Canada. 20-23 October 2011

BackgroundThe regulatory assessment of novel food includes tests forallergy. The World Health Organization suggests tests inan animal model of allergy despite the lack of a validatedmodel. We aimed to confirm if C3H/HeJ mice wouldrespond to food of high allergenic potential (peanut), butnot to food of low allergenic potential (turkey, potato,spinach).

MethodsIn the first study, C3H/HeJ mice were orally treated, onceper week for two weeks, with adjuvant and 0 or 2 mg ofpeanut or turkey. A second study used adjuvant and 0,0.1, 1 or 2 mg of peanut, potato or spinach. Blood IgEantibodies and spleen interleukin-4 were quantified.

ResultsMice treated with 2 mg peanut developed peanut-specificIgE levels which were significantly higher than controlmice (p<0.001, n=10/group). Mice treated with 2 mg tur-key developed a similar IgE response to turkey (p<0.001,n=10/group). In the second study, allergy was only trig-gered in one of ten mice treated with 2 mg peanut. Twoof ten mice exposed to 1 mg potato had a response.There were no IgE responders to spinach. Spleen cellsfrom both the peanut- and the spinach-treated micesecreted more allergy-promoting interleukin-4 than con-trols (p<0.01, n=7-24/group). Levels were not modified inpotato-treated mice.

ConclusionsC3H/HeJ mice developed food allergy markers to peanut.However, the incidence varied between experiments.

Some mice developed a similar response to foods withlow allergenic potential. Thus, this model may not beappropriate for safety assessment of novel food.

Author details1Toxicology Research Division, Bureau of Chemical Safety, Food Directorate,Health Canada, Ottawa, ON, K1A 0L2, Canada. 2Scientific Services Division,Bureau of Chemical Safety, Food Directorate, Health Canada, Ottawa, ON,K1A 0L2, Canada.

Published: 14 November 2011

doi:10.1186/1710-1492-7-S2-A1Cite this article as: Lefebvre et al.: Testing an emerging animal modelfor use in the allergenicity assessment of food. Allergy, Asthma & ClinicalImmunology 2011 7(Suppl 2):A1.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

1Toxicology Research Division, Bureau of Chemical Safety, Food Directorate,Health Canada, Ottawa, ON, K1A 0L2, CanadaFull list of author information is available at the end of the article

Lefebvre et al. Allergy, Asthma & Clinical Immunology 2011, 7(Suppl 2):A1http://www.aacijournal.com/content/7/S2/A1 ALLERGY, ASTHMA & CLINICAL

IMMUNOLOGY

© 2011 Lefebvre et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.